Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001197350-26-000002

CHIEF FINANCIAL OFFICER sold 1,053 shares at $96.19 ($101,290)

  • CHIEF FINANCIAL OFFICER acquired 2,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER 2026-01-23 Option exercise +2,667 44,794 D
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER 2026-01-26 Sale −1,053 $96.19 $101,290 43,741 D
Derivatives
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER 2026-01-23 Option exercise · Restricted Stock Units −2,667 2,666 D
Open-market sales · 1,053 sh · avg $96.19 · $101,290
Loading xslF345X05/form4-01272026_040108.xml…